Ocular Therapeutix, Inc. - Product Pipeline Analysis

1
Ocular Therapeutix, Inc. - Product Pipeline
AnalysisMarket Research Reports Distributor
- Aarkstore.com have vast database on market
research reports, company financials, company
profiles, SWOT analysis, company report, company
statistics, strategy review, industry report,
industry research to provide excellent and
innovative service to our report
buyers.Aarkstore.com have very interactive
search feature to browse across more than
2,50,000 business industry reports. We are built
on the premise that reading is valuable, capable
of stirring emotions and firing the imagination.
Whether you're looking for new market research
report product trends or competitive industry
analysis of a new or existing market,
Aarkstore.com has the best resource offerings and
the expertise to make sure you get the right
product every time.
2
Ocular Therapeutix, Inc. - Product Pipeline
Analysis

• SummaryOcular Therapeutix, Inc. (Ocular )
  develops ophthalmic therapeutic products using
  hydrogel technology. The hydrogel technology
  consists of polyethylene glycol (PEG), widely
  considered an inert and biocompatible material
  which can be customized as per the use. Its
  product portfolio includes ReSure Adherent Ocular
  Bandage, is a synthetic ocular bandag for
  ophthalmic surgery and ReSure Sealant, a
  synthetic and biocompatible hydrogel that creates
  a temporary, soft, and lubricious surface barrier
  to protect clear corneal incisions in the
  immediate post-operative period and
  prostaglandin analog punctum plugs that are
  hydrogel-based punctum plug depots to deliver
  prostaglandin analogs to treat glaucoma.
  Currently, it is developing ophthalmic drug
  delivery systems for the management and treatment
  of a wide range of anterior and posterior segment
  diseases. It is in the preclinical or clinical
  stage of development of the therapeutic products
  comprising hydrogel sealants, Resure sealant
  punctum plugs, glaucoma, post-operative
  inflammation, bacterial conjunctivitism and
  injectable depots, Vitreoretinal. Ocular is
  headquarterd in Bedford, the US.In February
  2012, the company received IDE approval from the
  U.S. Food and Drug Administration to conduct a
  pivotal clinical trial with ReSure Sealant.This
  report is a source for data, analysis and
  actionable intelligence on the Ocular
  Therapeutix, Inc. portfolio of pipeline products.
  The report provides detailed analysis on each
  pipeline product with information on the
  indication, the development stage, trial phase,
  product milestones, pipeline territory, estimated
  approval date, and estimated launch dateEach
  pipeline product is profiled to cover information
  on product description, function, technology,
  indication, and application. The report is also
  supplemented with a detailed company profile and
  information on clinical trials, wherever
  applicable.This report is built using data and
  information sourced from proprietary databases,
  primary and secondary research and in-house
  analysis by GlobalDatas team of industry experts.

3

• Scope- Detailed company profile with
  information on business description, key company
  facts, major products and services, key
  competitors, key employees, locations and
  subsidiaries and recent developments.- Detailed
  coverage on all the pipeline products, by
  equipment type, by therapy area, by development
  stage, and by trial phase.- Information on
  product milestones and pipeline territory for
  each product, the estimated approval date, and
  estimated launch date.- Profile of each pipeline
  product with additional information on product
  description, function, technology, indication(s),
  and application.- Data on relevant clinical
  trials and product patent details, wherever
  applicable.- Information on clinical trial,
  wherever applicable, is supplemented with
  information on trial phase, trial status, trial
  objective, trial design, target patients, unique
  physician identifier, primary point, secondary
  point, acronym, participants inclusion,
  participants exclusion, interventions, trial
  results, trial start date, trial end date, study
  type, trial site, trial funding, age eligibility,
  and gender eligibility.
• Reasons to Buy- Develop business strategies by
  understanding the trends and developments driving
  the medical devices pipeline and technology
  landscape globally.- Design and develop your
  product development, marketing and sales
  strategies.- Exploit MA opportunities by
  identifying market players with the most
  innovative pipeline.- Develop market-entry and
  market expansion strategies.- Exploit
  in-licensing and out-licensing opportunities by
  identifying products, most likely to ensure a
  robust return.- Identify emerging players with
  potentially strong product portfolio and create
  effective counter-strategies to gain competitive
  advantage.- Develop competition strategies by
  identifying the status and likely launch of your
  competitors pipeline products through review of
  the clinical trials, stage and phase of
  development, etc.- Which are the next high-value
  products that your competitor would add in its
  portfolio? identify, understand and capitalize.

4

• List of Tables 3List of Figures 4Key Facts
  5Ocular Therapeutix, Inc. - Major Products and
  Services 6Ocular Therapeutix, Inc. Pipeline
  Products by Equipment Type 7Ocular Therapeutix,
  Inc. Pipeline Products by Development Stage
  9Ocular Therapeutix, Inc. Pipeline Products by
  Therapy Area 11Ocular Therapeutix, Inc. Pipeline
  Products by Trial Phase 13Ocular Therapeutix,
  Inc. Pipeline Products by Milestone Summary
  15Galucoma Punctum Plug 17Galucoma Punctum Plug
  Product Status 17Galucoma Punctum Plug Product
  Description 17Galucoma Punctum Plug Product
  Patent Details 17Moxifloxacin Punctum Plug
  25Moxifloxacin Punctum Plug Product Status
  25Moxifloxacin Punctum Plug Product Description
  25Moxifloxacin Punctum Plug Product Milestone
  25Post Surgical Inflammation Punctum Plug
  27Post Surgical Inflammation Punctum Plug
  Product Status 27Post Surgical Inflammation
  Punctum Plug Product Description 27Post Surgical
  Inflammation Punctum Plug Product Patent Details
  27ReSure Sealant 35ReSure Sealant Product
  Status 35ReSure Sealant Product Description
  35ReSure Sealant Product Milestone 35ReSure
  Sealant Clinical Trial 36Ocular Therapeutix,
  Inc. - Key Competitors 40Ocular Therapeutix,
  Inc. - Key Employees 41Ocular Therapeutix, Inc.
  - Locations And Subsidiaries 42Head Office
  42Recent Developments 43Ocular Therapeutix,
  Inc., Recent Developments 43Jul 23, 2012 Ocular
  Therapeutix Discloses Promising Results For
  Extended Release Treatment Of Glaucoma
  43Appendix 44Methodology 44About GlobalData
  44Contact Us 44Disclaimer 44

5

• List of Tables Ocular Therapeutix, Inc., Key
  Facts 1Ocular Therapeutix, Inc. Key Pipeline
  Products by Equipment Type 1Ocular Therapeutix,
  Inc. Key Pipeline Products by Therapy Area
  1Ocular Therapeutix, Inc. Key Pipeline Products
  by Development Stage 1Ocular Therapeutix, Inc.
  Key Pipeline Products by Trial Phase 1Ocular
  Therapeutix, Inc., Key Facts 5Ocular
  Therapeutix, Inc., Major Products and Services
  6Ocular Therapeutix, Inc. Number of Pipeline
  Products by Equipment Type 7Ocular Therapeutix,
  Inc. Pipeline Products by Equipment Type 8Ocular
  Therapeutix, Inc. Number of Pipeline Products by
  Development Stage 9Ocular Therapeutix, Inc.
  Pipeline Products by Development Stage 10Ocular
  Therapeutix, Inc. Number of Pipeline Products by
  Therapy Area 11Ocular Therapeutix, Inc. Pipeline
  Products by Therapy Area 12Ocular Therapeutix,
  Inc. Number of Pipeline Products by Trial Phase
  13Ocular Therapeutix, Inc. Pipeline Products by
  Trial Phase 14Ocular Therapeutix, Inc. Number of
  Pipeline Products By Milestone Summary 15Ocular
  Therapeutix, Inc. Pipeline Products by Milestone
  Summary 16Galucoma Punctum Plug - Product Status
  17Galucoma Punctum Plug - Product Description
  17Galucoma Punctum Plug - Patent Details1
  17Galucoma Punctum Plug - Patent Details2
  18Galucoma Punctum Plug - Patent Details3
  18Galucoma Punctum Plug - Patent Details4
  19Galucoma Punctum Plug - Patent Details5
  19Galucoma Punctum Plug - Patent Details6
  20Galucoma Punctum Plug - Patent Details7
  21Galucoma Punctum Plug - Patent Details8
  21Galucoma Punctum Plug - Patent Details9
  22Galucoma Punctum Plug - Patent Details10
  22Galucoma Punctum Plug - Patent Details11
  23Galucoma Punctum Plug - Patent Details12
  23Galucoma Punctum Plug - Patent Details13
  24Moxifloxacin Punctum Plug - Product Status 25

6
Moxifloxacin Punctum Plug - Product Description
25Moxifloxacin Punctum Plug - Product Milestone
25Post Surgical Inflammation Punctum Plug -
Product Status 27Post Surgical Inflammation
Punctum Plug - Product Description 27Post
Surgical Inflammation Punctum Plug - Patent
Details1 27Post Surgical Inflammation Punctum
Plug - Patent Details2 28Post Surgical
Inflammation Punctum Plug - Patent Details3
28Post Surgical Inflammation Punctum Plug -
Patent Details4 29Post Surgical Inflammation
Punctum Plug - Patent Details5 29Post Surgical
Inflammation Punctum Plug - Patent Details6
30Post Surgical Inflammation Punctum Plug -
Patent Details7 30Post Surgical Inflammation
Punctum Plug - Patent Details8 31Post Surgical
Inflammation Punctum Plug - Patent Details9
31Post Surgical Inflammation Punctum Plug -
Patent Details10 32Post Surgical Inflammation
Punctum Plug - Patent Details11 32Post Surgical
Inflammation Punctum Plug - Patent Details12
33Post Surgical Inflammation Punctum Plug -
Patent Details13 33ReSure Sealant - Product
Status 35ReSure Sealant - Product Description
35ReSure Sealant - Product Milestone 35ReSure
Sealant - Novel Tissue Adhesive Shows Promise in
Cataract Surgery 36ReSure Sealant - Initial
Evaluation of A Hydrogel Ocular Bandage Used In
Cataract Surgery Single Site Experience
37ReSure Sealant - A Premarket Pivotal Clinical
Trial Completes Enrollment for ReSure Sealant
Study 38Ocular Therapeutix, Inc., Key Employees
41 List of Figures Ocular Therapeutix, Inc.
Pipeline Products by Equipment Type 7Ocular
Therapeutix, Inc. Pipeline Products by
Development Stage 9Ocular Therapeutix, Inc.
Pipeline Products by Therapy Area 11Ocular
Therapeutix, Inc. Pipeline Products by Trial
Phase 13Ocular Therapeutix, Inc. Pipeline
Products by Milestone Summary 15 
7

• For more information, please visit
• http//www.aarkstore.com/reports/Ocular-Therapeuti
  x-Inc-Product-Pipeline-Analysis-240131.html
• Or email us at contact_at_aarkstore.com or call
  919272852585
• http//www.aarkstore.com/search/viewresults.asp?se
  archProduct20Pipeline20AnalysisPubId
• pagenum1
• Related Reports
• 2013 French Hospital Hematology and Flow
  Cytometry Market
• United Arab Emirates In Vitro Diagnostics
  Investment Opportunities, Analysis and Forecasts
  to 2018
• Chile In Vitro Diagnostics Investment
  Opportunities, Analysis and Forecasts to 2018
• Norway In Vitro Diagnostics Investment
  Opportunities, Analysis and Forecasts to 2018
• Aleva Neurotherapeutics SA - Product Pipeline
  Analysis.
• DiaPat GmbH - Product Pipeline Analysis.
• Manhattan Scientifics, Inc. (MHTX) - Product
  Pipeline Analysis.
• MicroTransponder Inc. - Product Pipeline
  Analysis.

8

• Contact Us
• Aarkstore Enterprise
• Tel [phone]
• Mobile No08149852585
• Email contact_at_aarkstore.com
• Website http//www.aarkstore.com
• Blog http//www.emarketreports.com
• http//teju-aarkstoreenterprise.blogspot.in
• Follow us on twitter http//twitter.com/aarkstore
  dotcom
• http//in.linkedin.com/in/aarkstore
• http//www.facebook.com/aarkstoreenterprise